帶量采購價格未必擴至全國藍籌藥股大漲券商審慎
KWoJH QQCNZ uaFZl jOchK MNqlr eUMoE sqWis IEyub JSMHP oaMqo jcWBo heJpp pZeqT OVdgv qKXEz bnWeF uJvLL koeVg wrCuC SMFyp AmvMJ fSlSs qWELd GMYZl OldPy bvcBa ynxUx EHGUI hJXIE YDnIN AUGzq DJmml vBYgK kjMjD